

Our Mission
We’re redefining breast health through accessible, intuitive, and affordable technology. Our mission is to empower women to build awareness and confidence in their bodies-independently, privately, and from home.

Our Mission
We’re redefining breast health through accessible, intuitive, and affordable technology. Our mission is to empower women to build awareness and confidence in their bodies-independently, privately, and from home.
Clinical trials with Solis Mammography and Radnet imaging in the works, follow us for results
Feminai's patented technology combines advanced wearable sensors with AI-powered analysis to detect physiological changes associated with breast tissue density and blood flow.
In first-in-human clinical trials conducted at Sheba Medical Center our technology demonstrated
96% sensitivity and a 98% negative predictive value (NPV).


Clinical Validation
Feminai Validation Study
Conducted at Sheba Medical Center, our clinical validation study demonstrated high sensitivity and specificity across a diverse population of women with both normal and abnormal mammography findings.
These results support the potential of Feminai's wearable AI platform as an accessible and reliable breast health assessment solution.


.png)